Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Andratschke

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2021
Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositisM Sharabiani, E Clementel, N Andratschke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 24, 2013
Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapyM Essler, J Wantke, B Mayer, et al.
Radiation Oncology (London, England)|September 27, 2021
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancerJ Schaule, M Chamberlain, L Wilke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2012
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastasesR A Bundschuh, N Andratschke, J Dinges, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2020
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and ZugR A Stahel, A Curioni-Fontecedro, S Rohrmann, et al.
EJNMMI Research|July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patientsM Pavic, M Bogowicz, J Kraft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological studyD Gramatzki, P Roth, E J Rushing, et al.
Radiation Oncology (London, England)|April 16, 2022
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trialJ Ristau, J Hörner-Rieber, C Buchele, et al.
Radiation Oncology (London, England)|May 2, 2021
Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedureJ-J Stelmes, E Vu, V Grégoire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2023
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastasesM Guckenberger, N Andratschke, C Belka, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2021
Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositisM Sharabiani, E Clementel, N Andratschke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 24, 2013
Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapyM Essler, J Wantke, B Mayer, et al.
Radiation Oncology (London, England)|September 27, 2021
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancerJ Schaule, M Chamberlain, L Wilke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2012
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastasesR A Bundschuh, N Andratschke, J Dinges, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2020
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and ZugR A Stahel, A Curioni-Fontecedro, S Rohrmann, et al.
EJNMMI Research|July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patientsM Pavic, M Bogowicz, J Kraft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological studyD Gramatzki, P Roth, E J Rushing, et al.
Radiation Oncology (London, England)|April 16, 2022
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trialJ Ristau, J Hörner-Rieber, C Buchele, et al.
Radiation Oncology (London, England)|May 2, 2021
Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedureJ-J Stelmes, E Vu, V Grégoire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2023
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastasesM Guckenberger, N Andratschke, C Belka, et al.
Pageof 3